- List
- By Topic
- On Map
- Search Details

Restless Legs Syndrome
Need help? See RSS Feeds
Choose a feed type:

Restless Legs Syndrome (219 records)
Need help? See Downloading Content for Analysis
For Advanced Users: Full Study Record XML Download
1 | NCT03337529 | Recruiting | Restless Legs Syndrome in Hemodialysis Patients |
|
|
Interventional | Not Applicable |
|
Other |
|
|
25 | All | 18 Years and older (Adult, Senior) | NCT03337529 | 10082017 | September 15, 2017 | January 2018 | March 2018 | November 9, 2017 | November 14, 2017 |
|
||
2 | NCT03218969 | Not yet recruiting | Treatment of Restless Leg Syndrome (RLS) Augmentation With Ecopipam, a D1 Specific Antagonist |
|
|
Interventional | Phase 1 Phase 2 |
|
Other |
|
|
10 | All | 18 Years to 80 Years (Adult, Senior) | NCT03218969 | Pro#00016705 | RLS-Ecopipam | September 30, 2017 | September 15, 2018 | October 15, 2018 | July 17, 2017 | August 22, 2017 |
|
|
3 | NCT02419014 | Active, not recruiting | Cranial Electrotherapy for Military Beneficiaries With Restless Legs Syndrome |
|
|
Interventional | Not Applicable |
|
U.S. Fed / Other |
|
|
48 | All | 18 Years and older (Adult, Senior) | NCT02419014 | 52H13 | CES in RLS | February 2014 | February 2017 | February 2017 | April 17, 2015 | July 4, 2016 |
|
|
4 | NCT03249779 | Recruiting | Treatment of RLS/WED Symptoms Through Sensory Counter-stimulation |
|
|
Interventional | Not Applicable |
|
Other |
|
|
10 | All | 18 Years and older (Adult, Senior) | NCT03249779 | 16-005286 | RLS/WED | December 2016 | June 2018 | June 2018 | August 15, 2017 | January 9, 2018 |
|
|
5 | NCT02386423 | Completed | RESTIFFIC™ Foot Wrap Reduces Moderate to Severe Restless Leg Syndrome |
|
|
Interventional | Not Applicable |
|
Other |
|
|
30 | All | 18 Years to 75 Years (Adult, Senior) | NCT02386423 | Sorg1 | RESTIFFIC | April 2009 | April 2011 | November 2011 | March 11, 2015 | March 11, 2015 |
|
|
6 | NCT02117076 | Terminated | Blinded, Randomized Study of Gabapentin (Neurontin®) and Gabapentin Enacarbil (Horizant™) in Restless Leg Syndrome |
|
|
Interventional | Phase 4 |
|
Other |
|
|
5 | All | 18 Years to 80 Years (Adult, Senior) | NCT02117076 | RLS and Gabapentin or Horizant | April 2014 | June 2016 | April 17, 2014 | June 29, 2016 |
|
|||
7 | NCT01113710 | Completed Has Results |
Non-interventional Study (NIS) in Patients With Restless Legs Syndrome in Daily Practise |
|
|
Observational |
|
Industry |
|
|
687 | All | 18 Years and older (Adult, Senior) | NCT01113710 | SP0948 | RLS-Practise | May 2010 | July 2011 | July 2011 | April 30, 2010 | September 28, 2012 | September 28, 2012 |
|
|
8 | NCT02526277 | Recruiting | A Study on the Use of the MMF07 Foot Massager and Heat Therapy Treatments for Restless Leg Syndrome |
|
|
Interventional | Phase 3 |
|
Other |
|
|
40 | All | 18 Years to 75 Years (Adult, Senior) | NCT02526277 | 2015H0107 | July 2015 | July 2018 | August 18, 2015 | September 26, 2017 |
|
|||
9 | NCT01192503 | Terminated | Safety and Efficacy of Rasagiline in Restless Legs Syndrome |
|
|
Interventional | Phase 2 Phase 3 |
|
Other / Industry |
|
|
52 | All | 18 Years and older (Adult, Senior) | NCT01192503 | 14630 | RAS-RLS | September 2010 | June 2012 | August 2012 | September 1, 2010 | February 11, 2013 |
|
|
10 | NCT02633657 | Withdrawn | A Pharmacokinetic and Safety Evaluation of HORIZANT (Gabapentin Enacarbil) in Adolescents With Moderate-to-Severe Primary RLS |
|
|
Interventional | Phase 1 |
|
Industry |
|
|
0 | All | 13 Years to 17 Years (Child) | NCT02633657 | XP108 | RLS | January 2016 | July 19, 2017 | July 19, 2017 | December 17, 2015 | November 6, 2017 |
|
|
11 | NCT01675323 | Completed | Glutamate, Hyperarousal and Restless Legs Syndrome |
|
Observational |
|
Other / NIH |
|
|
77 | All | 18 Years and older (Adult, Senior) | NCT01675323 | NA_00073951 | August 2012 | July 2016 | July 2016 | August 29, 2012 | March 1, 2017 |
|
||||
12 | NCT02484768 | Withdrawn | IV Iron Treatment of Restless Legs Syndrome |
|
|
Interventional | Phase 2 |
|
Industry |
|
|
0 | All | 18 Years and older (Adult, Senior) | NCT02484768 | P-RLS-01 | January 2015 | February 2015 | February 2015 | June 30, 2015 | June 30, 2015 | |||
13 | NCT00530790 | Completed Has Results |
Clinical Evaluation of Ropinirole CR-RLS ( SK&F101468)Tablets in Restless Legs Syndrome |
|
|
Interventional | Phase 2 |
|
Industry |
|
|
35 | All | 18 Years to 79 Years (Adult, Senior) | NCT00530790 | 107846 | August 2007 | February 2008 | February 2008 | September 17, 2007 | February 28, 2017 | July 24, 2009 |
|
|
14 | NCT03063190 | Recruiting | Cholecalciferol Supplementation in Restless Leg Syndrome in Patients With Chronic Kidney Disease |
|
|
Interventional | Phase 4 |
|
Other |
|
|
100 | All | 18 Years and older (Adult, Senior) | NCT03063190 | RLS vitamin D | RLS | March 31, 2017 | March 31, 2018 | March 2019 | February 24, 2017 | May 17, 2017 |
|
|
15 | NCT01823354 | Recruiting | Executive Dysfunction in Restless Legs Syndrome: Clinical Correlates and Outcome After Therapeutic Management |
|
|
Interventional | Not Applicable |
|
Other |
|
|
140 | All | 18 Years to 66 Years (Adult, Senior) | NCT01823354 | 8964 | November 2012 | July 2019 | December 2019 | April 4, 2013 | April 2, 2018 |
|
||
16 | NCT01109537 | Completed | Altered Brain GABA and Glutamate in Restless Legs Syndrome |
|
Observational |
|
Other / Industry |
|
|
75 | All | 18 Years and older (Adult, Senior) | NCT01109537 | BWH-2010-12345 | RLS | April 2010 | May 2014 | May 2014 | April 23, 2010 | January 7, 2015 |
|
|||
17 | NCT01967303 | Completed | Restless Legs Syndrome in Stroke Patients |
|
Observational |
|
Other |
|
|
447 | All | 18 Years and older (Adult, Senior) | NCT01967303 | 3186 | January 2008 | December 2008 | December 2008 | October 22, 2013 | October 22, 2013 | |||||
18 | NCT02633683 | Enrolling by invitation | An Extension Study to Evaluate the Efficacy and Safety of HORIZANT in Adolescents With Moderate-to-Severe Primary RLS |
|
|
Interventional | Phase 4 |
|
Industry |
|
|
144 | All | 13 Years to 17 Years (Child) | NCT02633683 | XP110 | RLS | January 2016 | May 2024 | July 2024 | December 17, 2015 | November 6, 2017 |
|
|
19 | NCT00806026 | Completed Has Results |
Long Term Study Of Pregabalin In Idiopathic Restless Legs Syndrome Patients |
|
|
Interventional | Phase 3 |
|
Industry |
|
|
731 | All | 18 Years and older (Adult, Senior) | NCT00806026 | A0081186 | RLS | December 2008 | May 2011 | May 2011 | December 10, 2008 | September 27, 2012 | September 27, 2012 |
|
20 | NCT01521663 | Completed | Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS) |
|
|
Interventional | Phase 2 |
|
Industry |
|
|
159 | All | 18 Years to 70 Years (Adult, Senior) | NCT01521663 | IPX159-B11-02 | November 2011 | February 2013 | February 2013 | January 31, 2012 | February 1, 2017 |
|
||
21 | NCT01538147 | Completed | Restless Leg Syndrome and Severe Preeclampsia |
|
Observational |
|
Other |
|
|
310 | Female | Child, Adult, Senior | NCT01538147 | MHST2012-02 | August 1, 2017 | November 30, 2017 | December 15, 2017 | February 23, 2012 | January 4, 2018 |
|
||||
22 | NCT01861652 | Withdrawn | Vasculaire Leg Compression Device for the Treatment of Restless Legs Syndrome - A Prospective Clinical Study |
|
|
Interventional | Not Applicable |
|
U.S. Fed |
|
|
0 | All | 18 Years and older (Adult, Senior) | NCT01861652 | 388140 | July 2013 | January 2014 | May 23, 2013 | June 16, 2015 |
|
|||
23 | NCT01931878 | Completed Has Results |
Investigation of Efficacy of incobotulinumtoxinA (Xeomin) in Relieving Symptoms of Restless Leg Syndrome. |
|
|
Interventional | Phase 2 |
|
Other / Industry |
|
|
24 | All | 18 Years and older (Adult, Senior) | NCT01931878 | 1206010332 | September 2012 | August 2015 | August 2015 | August 29, 2013 | March 21, 2016 | March 21, 2016 |
|
|
24 | NCT03053427 | Active, not recruiting | A Study of Oral Dosing of Gabapentin Enacarbil in Japanese Restless Legs Syndrome Patients |
|
|
Interventional | Phase 4 |
|
Industry |
|
|
375 | All | 20 Years to 80 Years (Adult, Senior) | NCT03053427 | 8825-CL-0101 | March 30, 2017 | September 2018 | September 2018 | February 15, 2017 | April 13, 2018 |
|
||
25 | NCT01981941 | Completed | Post-marketing Study of Gabapentin Enacarbil to Evaluate the Effect in Restless Leg Syndrome (RLS) Patients With Moderate Renal Impairment |
|
|
Interventional | Phase 4 |
|
Industry |
|
|
19 | All | 20 Years to 80 Years (Adult, Senior) | NCT01981941 | 8825-CL-0103 | May 2013 | May 2015 | May 2015 | November 13, 2013 | February 17, 2017 |
|
||
26 | NCT02025608 | Completed | Autonomic Function and Cardiovascular Risk in Restless Legs Syndrome |
|
|
Interventional | Phase 4 |
|
Other |
|
|
20 | All | 30 Years to 65 Years (Adult) | NCT02025608 | NSI.13.01 320030_144007 |
AUTOREST | December 2013 | December 31, 2016 | December 31, 2016 | January 1, 2014 | January 24, 2017 |
|
|
27 | NCT01174459 | Completed Has Results |
Survey on Long-Term Use of BI-Sifrol® Tablets in Patients With Restless Legs Syndrome |
|
Observational |
|
Industry |
|
|
571 | All | 15 Years and older (Child, Adult, Senior) | NCT01174459 | 248.678 | August 2010 | August 2013 | August 2013 | August 3, 2010 | August 29, 2014 | August 29, 2014 |
|
|||
28 | NCT01494766 | Completed | Efficacy of Tyrosine in Restless Legs Syndrome |
|
|
Interventional | Not Applicable |
|
Other |
|
|
5 | All | 18 Years to 80 Years (Adult, Senior) | NCT01494766 | CR-11-146 | January 2012 | May 2012 | November 2012 | December 19, 2011 | April 27, 2017 |
|
||
29 | NCT01562743 | Completed Has Results |
A Long-Term Extension Trial From Late Phase II of SPM 962 in Patients With Restless Legs Syndrome |
|
|
Interventional | Phase 2 |
|
Industry |
|
|
185 | All | 20 Years to 79 Years (Adult, Senior) | NCT01562743 | 243-07-004 | RLS | August 2008 | October 2010 | October 2010 | March 26, 2012 | April 23, 2014 | April 23, 2014 | |
30 | NCT01569464 | Completed Has Results |
Rotigotine Effect on All-day Functioning and Quality of Life in Subjects With Moderate to Severe Restless Legs Syndrome (RLS) |
|
|
Interventional | Phase 3 |
|
Industry |
|
|
150 | All | 18 Years to 75 Years (Adult, Senior) | NCT01569464 | RL0003 | RESTORE | March 2012 | April 2013 | April 2013 | April 3, 2012 | August 26, 2014 | August 26, 2014 |
|
31 | NCT02658188 | Completed | Long-term Efficacy and Safety of Gabapentin Enacarbil in Japanese Restless Legs Syndrome Patients |
|
|
Interventional | Phase 3 |
|
Industry |
|
|
182 | All | 20 Years to 80 Years (Adult, Senior) | NCT02658188 | 8825-CL-0005 | December 2007 | April 2009 | April 2009 | January 18, 2016 | February 4, 2016 |
|
||
32 | NCT00373542 | Completed | 12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome |
|
|
Interventional | Phase 4 |
|
Industry |
|
|
39 | All | 18 Years to 79 Years (Adult, Senior) | NCT00373542 | RRL103660 | (CR-RLS) | October 2006 | June 2007 | June 2007 | September 8, 2006 | October 28, 2016 |
|
|
33 | NCT00949806 | Completed | Restless Legs Syndrome Treatment With Botulinum Toxin |
|
|
Interventional | Phase 2 |
|
Other |
|
|
27 | All | 18 Years and older (Adult, Senior) | NCT00949806 | CHUBX 2008/35 | SOXIS | August 2009 | May 2011 | November 2011 | July 30, 2009 | July 19, 2012 |
|
|
34 | NCT00834327 | Terminated | Efficacy and Safety Study of Aplindore in Patients With Restless Legs Syndrome |
|
|
Interventional | Phase 2 |
|
Industry |
|
|
230 | All | 18 Years and older (Adult, Senior) | NCT00834327 | Aplindore-250 | February 2009 | November 2009 | December 2009 | February 3, 2009 | October 14, 2009 |
|
||
35 | NCT00621517 | Completed Has Results |
Bupropion and Restless Legs Syndrome |
|
|
Interventional | Phase 2 Phase 3 |
|
Other |
|
|
60 | All | 18 Years and older (Adult, Senior) | NCT00621517 | ETSU-07-061f | February 2008 | July 2009 | July 2009 | February 22, 2008 | April 5, 2012 | April 5, 2012 |
|
|
36 | NCT01061372 | Withdrawn | 12-Week Efficacy And Safety Of Pregabalin In Treating Restless Legs Syndrome (RLS) Subjects |
|
|
Interventional | Phase 3 |
|
Industry |
|
|
0 | All | 18 Years and older (Adult, Senior) | NCT01061372 | A0081184 | May 2010 | August 2011 | August 2011 | February 3, 2010 | June 29, 2010 | |||
37 | NCT00656110 | Unknown † | Neuroma Injections to Treat Restless Legs Syndrome - RCT |
|
|
Interventional | Not Applicable |
|
Other |
|
|
60 | All | 18 Years and older (Adult, Senior) | NCT00656110 | LID-RLS-RCT-01 (None) |
April 2008 | November 2009 | December 2009 | April 10, 2008 | March 10, 2009 |
|
||
38 | NCT00479154 | Completed Has Results |
Botulinum Toxin to Treat Restless Legs Syndrome |
|
|
Interventional | Phase 1 Phase 2 |
|
NIH |
|
|
6 | All | 18 Years to 80 Years (Adult, Senior) | NCT00479154 | 070160 07-N-0160 |
May 2007 | April 2008 | April 2008 | May 28, 2007 | April 26, 2012 | April 26, 2012 |
|
|
39 | NCT02256215 | Unknown † | Vitamin D in the Treatment of Primary Restless Legs Syndrome |
|
|
Interventional | Phase 2 Phase 3 |
|
Other |
|
|
106 | All | 18 Years to 75 Years (Adult, Senior) | NCT02256215 | RLSD-1234 | December 2015 | December 2017 | October 3, 2014 | April 6, 2015 | ||||
40 | NCT02138357 | Withdrawn | Butrans for Treatment of Restless Legs Syndrome |
|
|
Interventional | Phase 4 |
|
Other |
|
|
0 | All | 25 Years to 75 Years (Adult, Senior) | NCT02138357 | 2013D004946 | Butrans | December 2014 | December 2016 | May 14, 2014 | January 7, 2015 |
|
||
41 | NCT03457571 | Completed | Clinical Observational Study: IBD Patients With Restless-legs-syndrome and Iron Deficiency Syndrome |
|
Observational |
|
Other |
|
|
353 | All | 18 Years and older (Adult, Senior) | NCT03457571 | EA4/132/13 | February 1, 2014 | February 28, 2015 | April 30, 2015 | March 7, 2018 | March 7, 2018 | |||||
42 | NCT01245777 | Completed | Restless Legs Syndrome With Iron Deficiency or Anaemia in the 3rd Trimester of Pregnancy |
|
|
Interventional | Phase 4 |
|
Other / Industry |
|
|
15 | Female | 18 Years and older (Adult, Senior) | NCT01245777 | ITiRiP-1 | October 2009 | December 2012 | December 2012 | November 22, 2010 | December 5, 2014 |
|
||
43 | NCT00530530 | Completed | ASP8825 - Study in Patients With Restless Legs Syndrome |
|
|
Interventional | Phase 2 |
|
Industry |
|
|
474 | All | 20 Years to 80 Years (Adult, Senior) | NCT00530530 | 8825-CL-0003 | September 2007 | January 2009 | January 2009 | September 17, 2007 | October 29, 2014 |
|
||
44 | NCT00676403 | Completed Has Results |
Lyrica Dose Response Study With Restless Legs Syndrome (RLS) Patients |
|
|
Interventional | Phase 2 |
|
Industry |
|
|
137 | All | 18 Years to 65 Years (Adult) | NCT00676403 | A0081183 | April 2008 | January 2009 | January 2009 | May 13, 2008 | July 7, 2010 | February 4, 2010 |
|
|
45 | NCT02248155 | Completed | Observational Study of Sifrol® in Patients With Primary Restless Legs Syndrome (RLS) |
|
|
Observational |
|
Industry |
|
|
2644 | All | Child, Adult, Senior | NCT02248155 | 248.618 | April 2006 | November 2006 | September 25, 2014 | September 25, 2014 | |||||
46 | NCT01382901 | Completed Has Results |
Intravenous (IV) Iron Preparation (VIT-45) in the Treatment of Restless Legs Syndrome (RLS) |
|
|
Interventional | Phase 2 |
|
Industry |
|
|
45 | All | 18 Years and older (Adult, Senior) | NCT01382901 | 1VIT05009 | March 2006 | July 2007 | July 2007 | June 27, 2011 | February 20, 2018 | June 27, 2011 | ||
47 | NCT02560766 | Recruiting | An Efficacy and Safety Evaluation of HORIZANT in Adolescents With Moderate-to-Severe Primary RLS |
|
|
Interventional | Phase 4 |
|
Industry |
|
|
132 | All | 13 Years to 17 Years (Child) | NCT02560766 | XP109 | RLS | February 2016 | October 2023 | October 2023 | September 25, 2015 | November 6, 2017 |
|
|
48 | NCT00996944 | Terminated Has Results |
Clinical Evaluation of Ropinirole IR (Immediate Release) Tablets in Patients Who Are Diagnosed With Symptomatic Restless Legs Syndrome (RLS) Associated With Chronic Kidney Disease (CKD) Managed With Haemodialysis (Including Haemofiltration and Haemodiafiltration) |
|
|
Interventional | Phase 2 |
|
Industry |
|
|
34 | All | 18 Years to 79 Years (Adult, Senior) | NCT00996944 | 113079 | November 2009 | June 2010 | June 2010 | October 16, 2009 | January 18, 2017 | June 13, 2011 |
|
|
49 | NCT01084551 | Completed Has Results |
Study of SPM 962 in Patients With Restless Legs Syndrome (RLS) |
|
|
Interventional | Phase 3 |
|
Industry |
|
|
284 | All | 20 Years to 79 Years (Adult, Senior) | NCT01084551 | 243-09-001 JapicCTI-101053 |
February 2010 | September 2011 | September 2011 | March 10, 2010 | June 5, 2014 | June 5, 2014 |
|
|
50 | NCT00991276 | Completed Has Results |
Polysomnography Study Of Pregabalin And Pramipexole Versus Placebo In Patients With Restless Legs Syndrome And Associated Sleep Disturbance |
|
|
Interventional | Phase 3 |
|
Industry |
|
|
85 | All | 18 Years and older (Adult, Senior) | NCT00991276 | A0081185 | December 2009 | June 2011 | June 2011 | October 7, 2009 | October 8, 2012 | October 8, 2012 |
|
† Study has passed its completion date and status has not been verified in more than two years.